BSX Q4 2025 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.3B+15.9% YoY

Gross Profit

$3.9B74.5% margin

Operating Income

$1.2B22.8% margin

Net Income

$668M12.6% margin

EPS (Diluted)

$0.45

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.0B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$43.7B

Total Liabilities

$19.2B

Stockholders' Equity

$24.2B

Cash & Equivalents

$2.0B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$4.6B	+15.9%
Gross Profit	$3.9B	$2.7B	+47.4%
Operating Income	$1.2B	$589M	+104.8%
Net Income	$668M	$566M	+18.0%

Revenue Segments

Cardiovascular

$3.5B66%

MedSurg

$1.8B34%

Geographic Segments

UNITED STATES

$5.8B75%

Non-US

$1.9B25%